Country: Malta
Language: English
Source: Medicines Authority
NORGESTIMATE, ETHINYLESTRADIOL
Janssen-Cilag International NV Turnhoutsewes 30, B-2340 Beerse, Belgium
G03AA11
NORGESTIMATE 250 µg ETHINYLESTRADIOL 35 µg
TABLET
NORGESTIMATE 250 µg ETHINYLESTRADIOL 35 µg
POM
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Withdrawn
2006-12-20
- 1 - PACKAGE LEAFLET: INFORMATION FOR THE USER CILEST ® 250/35 MICROGRAM TABLETS Norgestimate/ethinylestradiol Cilest is a registered trademark READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them. • IF ANY OF THE SIDE EFFECTS GETS SERIOUS, or if you notice any not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1 WHAT CILEST IS AND WHAT IT IS USED FOR 2 BEFORE YOU TAKE CILEST 3 HOW TO TAKE CILEST 3.3 A MISSED PILL 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE CILEST 6 FURTHER INFORMATION 1 WHAT CILEST IS AND WHAT IT IS USED FOR The name of your medicine is Cilest 250/35 microgram tablets. It is called ‘Cilest’ in this leaflet. Cilest is a combined oral contraceptive pill (‘the Pill’). YOU TAKE IT TO STOP GETTING PREGNANT. This low-dose contraceptive contains two types of female sex hormones, oestrogen and progestogen. These hormones prevent an egg being released from your ovaries so you can’t get pregnant. Also Cilest makes the fluid (mucus) in your cervix thicker, making it more difficult for sperm to enter the womb, and changes the lining of the womb so that fertilised eggs are unable to grow there. Cilest is a 21-day Pill - you take one each day for 21 days, followed by 7 days when you take no pills. THE BENEFITS OF TAKING THE PILL INCLUDE: • it is one of the most reliable reversible methods of contraception if used correctl Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CILEST ® 250/35 microgram Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients: Each tablet contains 250 micrograms norgestimate and 35 micrograms ethinyl estradiol. Excipients: Contains Lactose Anhydrous 89.007mg For a full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Tablet A dark blue, flat, bevel-edged tablet engraved “C” over “250” on both faces. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Hormonal contraception. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Adults: When used perfectly, without missing any pills, the chance of becoming pregnant is less than 1% (i.e. <1 pregnancy per 100 women in their first year of use). Typical failure rates are actually 5% in the first year. The chance of becoming pregnant increases with each missed pill during a menstrual cycle. Before starting Cilest, a thorough general medical and gynaecological examination (including the breasts and a cytological smear of the cervix) if appropriate should be carried out and the family medical history carefully noted. Disturbances of menstruation, such as oligomenorrhea and amenorrhea should be investigated prior to prescription. Disturbances of the clotting mechanisms should be ruled out if any members of the family have suffered from thrombo-embolic diseases (eg deep vein thrombosis, stroke, myocardial infarction) at a young age. Pregnancy must be excluded ideally by a pregnancy test. The woman should be instructed to carefully read the user leaflet and to adhere to the advice given. As a precaution, thorough medical examinations should be conducted at approximately six month intervals Read the complete document